Translational research in medication development for nicotine dependence.

Nat Rev Drug Discov

Department of Psychiatry and Abramson Cancer Center, University of Pennsylvania, 3535 Market Street, Suite 4100, Philadelphia, Pennsylvania 19104, USA.

Published: September 2007

A major obstacle to the development of medications for nicotine dependence is the lack of animal and human laboratory models with sufficient predictive clinical validity to support the translation of knowledge from laboratory studies to clinical research. This Review describes the animal and human laboratory paradigms commonly used to investigate the pathophysiology of nicotine dependence, and proposes how their predictive validity might be determined and improved, thereby enhancing the development of new medications.

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrd2361DOI Listing

Publication Analysis

Top Keywords

nicotine dependence
12
development medications
8
animal human
8
human laboratory
8
translational medication
4
medication development
4
development nicotine
4
dependence major
4
major obstacle
4
obstacle development
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!